论文部分内容阅读
肝门部胆管癌(HCC)的早期诊断困难,需多学科的方法。目前随着各种新技术(如超声内镜引导下细针穿刺活检术、经口胆管镜和望远镜)的开发,使内镜在恶性胆管狭窄诊断的敏感性方面有了新的进展。对于无法切除的HCC,内镜下姑息引流治疗发挥着越来越重要的作用。新出现的姑息疗法(如光动力治疗和管腔内近距离放射治疗)作为新兴的非手术方式对延长患者的生存时间可能具有意义,在未来联合手术切除中可能发挥辅助的治疗作用。
Early diagnosis of hilar cholangiocarcinoma (HCC) is difficult and requires a multidisciplinary approach. With the development of various new technologies (such as endoscopic ultrasonography guided fine needle aspiration biopsy, oral cholangioscopy and telescope), the endoscope has made new progress in the diagnosis of malignant biliary stricture. For unresectable HCC, endoscopic palliative drainage treatment plays an increasingly important role. Emerging palliatives, such as photodynamic therapy and intra-brachytherapy, as emerging non-surgical approaches may have implications for prolonging patient survival and may play an adjunct therapeutic role in future combined surgical resections.